The Game-Changing Wireless Mouse: Higround’s YUMA is Designed for Style and Performance
9.9.2024 22:50:00 CEST | Business Wire | Press release
Higround, the premier lifestyle and graphic gaming peripheral brand, is thrilled to announce its first-ever wireless gaming mouse: YUMA. Lightweight, meticulously designed, and built to perform, YUMA marks a new chapter in Higround’s mission to elevate every aspect of your gaming setup into a true expression of individual artistry.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240909711165/en/
The YUMA mouse launches with two colorways: RADAR and CELSHADE. (Photo: Business Wire)
Meet YUMA: Where Art Meets Performance
Every wireless mouse features hand-applied graphic artwork, ensuring that each mouse is fine-tuned to the minutest detail. It’s a true collector’s item that reflects Higround’s commitment to individuality and creative expression. Weighing in at just 49 grams, YUMA is a game-changer in the world of gaming mice, combining top-tier performance with unparalleled design aesthetics. With two distinct designs—RADAR and CELSHADE—the YUMA collection brings bold, unique visuals to your fingertips.
YUMA is more than just an aesthetically pleasing mouse; it packs serious gaming performance, featuring a 4KHz wireless polling rate for ultra-responsive, lag-free gameplay. Every click and movement registers with pinpoint accuracy, giving users the competitive edge they need to rise to the top.
Equipped with a battery life of up to 70 hours, YUMA ensures you stay in the game longer without the worry of frequent recharges. Whether you’re a casual gamer or a competitive esports player, YUMA delivers the reliability and performance you need while looking incredible on your desk.
Higround's Expansion Across the Desk Setup
With the introduction of YUMA, Higround continues its mission to transform every piece of your gaming setup into a canvas for personal expression. "We started Higround with the belief that your setup is an extension of who you are," says Rustin Sotoodeh, CEO and Creative Director of Higround. "With YUMA, we’re expanding Higround’s reach onto an even more technical piece of hardware, giving gamers a mouse that not only performs at the highest level but also stands out as a unique work of art."
“We're excited to introduce our new YUMA mouse, engineered with performance in mind and infused with our distinctive visual style,” says Higorund’s Principal Product Manager, Jeff Chang. “This release marks a significant step for Higround and we can't wait to show off our unique vision to the world.”
YUMA launches with its debut designs—RADAR and CELSHADE— on September 13 at 12 PM PT exclusively on Higround.
ABOUT HIGROUND
Higround is a lifestyle and computer peripheral brand that is the expression of elevated gaming culture. Founded by Rustin Sotoodeh and Kha Lu, Higround creates high-quality peripherals with unique designs that call back to the overarching cultures of fashion, gaming, and technology. Each collection features a unique collection of items that add personality to computer setups that are known to sell out in an instant. The brand is widely known for collaborations with iconic brands such as Pokemon, Beats by Dre, and One Piece. With their expansion into mice, Higround continues its journey to take over your gaming setup—one peripheral at a time. In 2021 the brand was acquired by esports giant, 100 Thieves.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240909711165/en/
Contacts
Kelly Kim
Kelly Kim
kkim@higround.co
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom